✦ LIBER ✦
Benefit in lung function improvement and side-effect profile of long-term responders: An analysis of 14 NSCLC patients treated for at least 9 months with gefitinib
✍ Scribed by Reck, Martin; Gatzemeier, Ulrich
- Book ID
- 119319236
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 332 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.